Researchers report positive preliminary experience with super pulse thulium fiber laser lithotripsy
March 11th 2021North American urologists analyzing outcomes from their initial experience treating urolithiasis with the high-power super pulse thulium fiber laser (Soltive) are encouraged by the results.
Apalutamide survival benefit in mCSPC sustained in long-term follow-up
February 13th 2021After adjusting for crossover using a preplanned sensitivity analysis, investigators for the pivotal phase 3 TITAN trial found a 48% reduction in the risk of death in patients treated with apalutamide plus ADT versus ADT alone.